Use of the anti-CD19 CAR T-cell therapy obecabtagene autoleucel (obe-cel; Aucatzyl) resulted in durable remissions among ...
The FDA said on Wednesday that it is investigating reports of blood cancers -- including life-threatening cases of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback